ArticleJournal of human hypertension2017
Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey.
Article in Journal of human hypertension, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Systematic literature review and meta-analysis of cardiovascular risk factor management in selected Asian countries.Journal of comparative effectiveness research · 2023Pooled it
- Trial
- Labour-type physical activity, metabolic dysregulation, and hypertension in rural older adults: rethinking work, exercise, and health in a cold-climate agricultural community.Frontiers in public health · 2026Article
- Epidemiological features of hypertension in a high-altitude population in Tibet, China: a cross-sectional study.BMC public health · 2025Article
- Analysis of Risk Factors for Acute First-Ever Ischemic Stroke in the Elderly Population of Eastern Liaoning Province: A Case-Control Study.International journal of general medicine · 2025Article
- Comparative Effects of Candesartan Versus Enalapril on Apelin, Visfatin, and Lipid Levels in Non-obese Hypertensive Patients.Medeniyet medical journal · 2024Article
- Hypertension prevalence in Iran's elderly according to new criteria: the Tehran Geriatric Eye Study.Journal of diabetes and metabolic disorders · 2023Article
- Awareness, Treatment, and Control of Hypertension among 10663 Adults Based on the Baseline Data of the Kherameh Cohort Study.The journal of Tehran Heart Center · 2023Article
- The Interaction between Occupational Stress and Smoking, Alcohol Drinking and BMI on Hypertension in Chinese Petrochemical Workers.International journal of environmental research and public health · 2022Article
- Epidemiological status quo of hypertension in elderly population in Changchun, China: a cross-sectional study.BMJ open · 2022Article
- The effects of the interaction between BMI and dyslipidemia on hypertension in adults.Scientific reports · 2022Article
- Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan.International journal of hypertension · 2022Article
- Disability Status and Its Influencing Factors Among Stroke Patients in Northeast China: A 3-Year Follow-Up Study.Neuropsychiatric disease and treatment · 2021Article
- Clinical Characteristics and Prognosis of Young Patients with Coronary Heart Disease.Medical science monitor : international medical journal of experimental and clinical research · 2020Article
- The association of outdoor temperature with blood pressure, and its influence on future cardio-cerebrovascular disease risk in cold areas.Journal of hypertension · 2020Article
- Bayesian Double Feature Allocation for Phenotyping with Electronic Health Records.Journal of the American Statistical Association · 2020Article
- Prevalence, awareness, treatment, and control of hypertension and their determinants: Results from the first cohort of non-communicable diseases in a Kurdish settlement.Scientific reports · 2019Article
- Article
- Urban-Rural disparities in status of hypertension in northeast China: a population-based study, 2017-2019.Clinical epidemiology · 2019Article
- microRNA-21 and hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension has been recognized as a major risk factor for cardiovascular disease. We aimed to analyze the current prevalence, awareness, treatment, and control of hypertension in northeast China. This cross-sectional survey adopted the multistage stratified random cluster sampling method to obtain a representative sample of adults aged 40 years or older in the general population of northeast China. Hypertension was defined as a systolic blood pressure (SBP) ≥ 140 mm Hg, or diastolic blood pressure (DBP) ≥ 90 mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of BP. Altogether 4052 participants were included with weighted prevalence of hypertension of 57.3%. Among them, 47.4% were aware of their condition; 78.8% took antihypertensive medication, but only 10.2% had their blood pressure controlled. Individuals who were overweight/obesity, with dyslipidemia, or diabetes were at a higher risk of hypertension; these people also more likely to be aware of their condition. Subjects with a personal history of stroke were more inclined to receive antihypertensive medication, but that did not necessarily translate to well-controlled hypertension. Moreover, dyslipidemia (OR = 0.600; 95% CI: 0.375, 0.960) were associated with poor hypertension control. Subjects using combination of antihypertensive medications (OR = 2.924; 95% CI: 1.606, 5.325) or with a family history of coronary heart disease were more likely to have their blood pressure controlled. Our study identified a high prevalence of hypertension in northeast China. Although awareness and treatment rates improved over the last decade, the control rate remained disproportionately and unacceptably low.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.